Literature DB >> 14991067

Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection.

Sumit K Subudhi1, Ping Zhou, Lisa M Yerian, Robert K Chin, James C Lo, Robert A Anders, Yonglian Sun, Lieping Chen, Yang Wang, Maria-Luisa Alegre, Yang-Xin Fu.   

Abstract

A number of studies have suggested B7-H1, a B7 family member, inhibits T cell responses. Therefore, its expression on nonlymphoid tissues has been proposed to prevent T cell-mediated tissue destruction. To test this hypothesis, we generated transgenic mice that expressed B7-H1 on pancreatic islet beta cells. Surprisingly, we observed accelerated rejection of transplanted allogeneic B7-H1-expressing islet beta cells. Furthermore, transgenic B7-H1 expression broke immune tolerance, as some of the mice spontaneously developed T cell-dependent autoimmune diabetes. In addition, B7-H1 expression increased CD8+ T cell proliferation and promoted autoimmunity induction in a T cell adoptive transfer model of diabetes. Consistent with these findings, B7-H1.Ig fusion protein augmented naive T cell priming both in vitro and in vivo. Our results demonstrate that B7-H1 can provide positive costimulation for naive T cells to promote allograft rejection and autoimmune disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14991067      PMCID: PMC351315          DOI: 10.1172/JCI19210

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  40 in total

1.  PD-1: an inhibitory immunoreceptor involved in peripheral tolerance.

Authors:  H Nishimura; T Honjo
Journal:  Trends Immunol       Date:  2001-05       Impact factor: 16.687

2.  Programmed death-1 targeting can promote allograft survival.

Authors:  Engin Ozkaynak; Liqing Wang; Andrew Goodearl; Kevin McDonald; Shixin Qin; Theresa O'Keefe; Thao Duong; Tammy Smith; Jose-Carlos Gutierrez-Ramos; James B Rottman; Anthony J Coyle; Wayne W Hancock
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

3.  Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity.

Authors:  Tyler J Curiel; Shuang Wei; Haidong Dong; Xavier Alvarez; Pui Cheng; Peter Mottram; Roman Krzysiek; Keith L Knutson; Ben Daniel; Maria Carla Zimmermann; Odile David; Matthew Burow; Alan Gordon; Nina Dhurandhar; Leann Myers; Ruth Berggren; Akseli Hemminki; Ronald D Alvarez; Dominique Emilie; David T Curiel; Lieping Chen; Weiping Zou
Journal:  Nat Med       Date:  2003-04-21       Impact factor: 53.440

4.  B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.

Authors:  Nicole Selenko-Gebauer; Otto Majdic; Andreas Szekeres; Gerald Höfler; Elisabeth Guthann; Ulf Korthäuer; Gerhard Zlabinger; Peter Steinberger; Winfried F Pickl; Hannes Stockinger; Walter Knapp; Johannes Stöckl
Journal:  J Immunol       Date:  2003-04-01       Impact factor: 5.422

5.  CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo.

Authors:  Qizhi Tang; Judy A Smith; Greg L Szot; Ping Zhou; Maria-Luisa Alegre; Kammi J Henriksen; Craig B Thompson; Jeffrey A Bluestone
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

6.  Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.

Authors:  Julia A Brown; David M Dorfman; Feng-Rong Ma; Elizabeth L Sullivan; Oliver Munoz; Clive R Wood; Edward A Greenfield; Gordon J Freeman
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

Review 7.  Negative T cell costimulation and islet tolerance.

Authors:  Wenda Gao; Gülçin Demirci; Xian Chang Li
Journal:  Diabetes Metab Res Rev       Date:  2003 May-Jun       Impact factor: 4.876

8.  Program death-1 engagement upon TCR activation has distinct effects on costimulation and cytokine-driven proliferation: attenuation of ICOS, IL-4, and IL-21, but not CD28, IL-7, and IL-15 responses.

Authors:  Frann Bennett; Deborah Luxenberg; Vincent Ling; I-Ming Wang; Kim Marquette; David Lowe; Nighat Khan; Geertruida Veldman; Kenneth A Jacobs; Viia E Valge-Archer; Mary Collins; Beatriz M Carreno
Journal:  J Immunol       Date:  2003-01-15       Impact factor: 5.422

9.  Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction.

Authors:  Shengdian Wang; Jürgen Bajorath; Dallas B Flies; Haidong Dong; Tasuku Honjo; Lieping Chen
Journal:  J Exp Med       Date:  2003-04-28       Impact factor: 14.307

10.  PD-1 inhibits antiviral immunity at the effector phase in the liver.

Authors:  Yoshiko Iwai; Seigo Terawaki; Masaya Ikegawa; Taku Okazaki; Tasuku Honjo
Journal:  J Exp Med       Date:  2003-07-07       Impact factor: 14.307

View more
  52 in total

Review 1.  T-cell activation and transplantation tolerance.

Authors:  Bhavana Priyadharshini; Dale L Greiner; Michael A Brehm
Journal:  Transplant Rev (Orlando)       Date:  2011-11-08       Impact factor: 3.943

Review 2.  The balance of immune responses: costimulation verse coinhibition.

Authors:  Sumit K Subudhi; Maria-Luisa Alegre; Yang-Xin Fu
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

3.  Costimulation and pancreatic autoimmunity: the PD-1/PD-L conundrum.

Authors:  Deepak Yadav; Nora Sarvetnick
Journal:  Rev Diabet Stud       Date:  2006-05-10

4.  DC-HIL is a negative regulator of T lymphocyte activation.

Authors:  Jin-Sung Chung; Kota Sato; Irene I Dougherty; Ponciano D Cruz; Kiyoshi Ariizumi
Journal:  Blood       Date:  2007-02-06       Impact factor: 22.113

5.  Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes.

Authors:  Ryoyo Ikebuchi; Satoru Konnai; Tomohiro Okagawa; Kazumasa Yokoyama; Chie Nakajima; Yasuhiko Suzuki; Shiro Murata; Kazuhiko Ohashi
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

6.  Divergent Function of Programmed Death-Ligand 1 in Donor Tissue versus Recipient Immune System in a Murine Model of Bronchiolitis Obliterans.

Authors:  Katharina Schütte-Nütgen; Olaf Boenisch; Hakima Harrach; Alicia Casey; Indira Guleria; Nader Najafian; Mohamed H Sayegh; Craig J Gerard; Meera Subramaniam
Journal:  Am J Pathol       Date:  2017-04-17       Impact factor: 4.307

7.  B7H1/CD80 interaction augments PD-1-dependent T cell apoptosis and ameliorates graft-versus-host disease.

Authors:  Ruishu Deng; Kaniel Cassady; Xiaofan Li; Sheng Yao; Mingfeng Zhang; Jeremy Racine; Jeffrey Lin; Lieping Chen; Defu Zeng
Journal:  J Immunol       Date:  2014-12-08       Impact factor: 5.422

Review 8.  Co-stimulatory and Co-inhibitory Pathways in Autoimmunity.

Authors:  Qianxia Zhang; Dario A A Vignali
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

9.  PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE.

Authors:  Bettina Schreiner; Samantha L Bailey; Tahiro Shin; Lieping Chen; Stephen D Miller
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

10.  Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.

Authors:  Tarvo Rajasalu; Helen Brosi; Cornelia Schuster; Andreas Spyrantis; Bernhard Otto Boehm; Lieping Chen; Jörg Reimann; Reinhold Schirmbeck
Journal:  Diabetes       Date:  2010-05-18       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.